Dr. Sarit Assouline
May 2017Research at the Lady Davis Institute

Promising therapy for relapsed patients with aggressive form of lymphoma

A unique phase 2 clinical trial, led by researchers in the Segal Cancer Centre at the JGH, has resulted in a remission of diffuse large B-cell lymphoma for patients who have relapsed and have a particularly dire prognosis.

READ MORE →